Adjuvant anabolic agents: A case report on the successful use of oxandrolone in an HIV-positive patient with chronic stasis ulceration

Journal of Wound, Ostomy and Continence Nursing

Volumn 28, Issue 4, 2001, Pages 215-218

  Cioroiu, Michael ^a   Hanan, Scott H ^a,b  

^a Cabrini Wound Care Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; OXANDROLONE;

ARTICLE; CASE REPORT; CHRONIC DISEASE; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; VARICOSIS; VIROLOGY; WOUND HEALING;

ANABOLIC AGENTS; CHRONIC DISEASE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; OXANDROLONE; TREATMENT OUTCOME; VARICOSE ULCER; WOUND HEALING;

EID: 0035408789     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjw.2001.116252     Document Type: Article

References (13)

1. Phillips TJ. Chronic cutaneous ulcers: etiology and epidemiology. J Invest Dermatol 1994;102: 38s-41s.
2. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130: 489-93.
3. Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV Infection in the United States, 1984 to 1992. JAMA 1996;276: 126-31.
4. Centers For Disease Control and Prevention. U.S. HIV and AIDS cases reported through December 1999. HIV AIDS Surveill Rep 1999;11:1-44.
5. Kotler DR, Tierney AR, Wang J, Pierson RN, Jr. Magnitude of body cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
6. Demling R, DeSanti L. Closure of the "non-healing wound" corresponds with correction of weight loss using the anabolic agent oxandrolone. Ostomy Wound Manage 1998;44:58-65.
7. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Mor Mortal Wkly Rep 1992;41:1-19.
8. Lord RV. Anorectal surgery in patients infected with human immunodeficiency virus: factors associated with delayed wound healing. Ann Surg 1997;226:92-9.
9. Morandi E, Merlini D, Salvaggio A, Foschi D, Trabucchi E. Prospective study of healing time after hemorrhoidectomy: influence of HIV infection, acquired immunodeficiency syndrome, and anal wound infection. Dis Colon Rectum 1999; 42:1140-4.
10. Risser JMH, Rabeneck L, Foote LW. Prevalence of wasting in men infected with human immunodeficiency virus seeking routine medical care in an outpatient clinic. J Am Diet Assoc 1995;95:1025-6.
11. Palenicek JP, Graham NM, He YD, Hoover DA, Oishi JS, Kingsley L, et al. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immun Defic Syndr Hum Retrovirol 1995;10:366-72.
12. Lyles RH, Tang AM, Smit E, Mellors JW, Margolick JB, Visscher BR, et al. Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS. J Acquir Immun Defic Syndr Hum Retrovirol 1999;22:386-94.
13. Sheffield-Moore M, Ferrando AA, Urban R, Wolf SE, et al. Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. Presented at the 81st Annual Meeting of the Endocrine Society; 1999 June 12-15; San Diego, California.